Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-27

Clinical Trial Update: Sirolimus Combined With ATRA for the Treatment of Auto-Immune Anemia [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update reports phase 2 and phase 3 evaluation of sirolimus combined with ATRA for autoimmune anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATRA (all-trans retinoic acid)
  • Sirolimus (Sirolimus)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Autoimmune Anemia | Phase 2, Phase 3 | Status: UNKNOWN